2021
DOI: 10.1016/j.ejphar.2021.173914
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of the role of non-coding RNAs in the pathophysiology of Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 27 publications
(14 citation statements)
references
References 64 publications
0
14
0
Order By: Relevance
“…A former study showed that hsa-miR-7, which was downregulated in the substantia nigra according to our review, is a direct regulator of SNCA, reducing its expression in a cell model and in an MPTP PD murine model [34]. Considering the miRNAs associated with both substantia nigra and putamen, we found that hsa-miR-34b and hsa-miR-95-hsa-miR-34b are associated with a reduction in the expression of alpha-synuclein [35], DJ-1, and Parkin [6], while hsa-miR-95 regulates the lysosomal function through the enzyme sulfatase-modifying factor 1 [36], and it was downregulated in pregnant women with multiple sclerosis [37]. To compare with another prevalent neurodegenerative disease, miRNAs such as hsa-miR-132 and hsa-miR-339-5p could be found in the brain of both PD and Alzheimer's disease patients [38].…”
Section: Discussionmentioning
confidence: 64%
See 1 more Smart Citation
“…A former study showed that hsa-miR-7, which was downregulated in the substantia nigra according to our review, is a direct regulator of SNCA, reducing its expression in a cell model and in an MPTP PD murine model [34]. Considering the miRNAs associated with both substantia nigra and putamen, we found that hsa-miR-34b and hsa-miR-95-hsa-miR-34b are associated with a reduction in the expression of alpha-synuclein [35], DJ-1, and Parkin [6], while hsa-miR-95 regulates the lysosomal function through the enzyme sulfatase-modifying factor 1 [36], and it was downregulated in pregnant women with multiple sclerosis [37]. To compare with another prevalent neurodegenerative disease, miRNAs such as hsa-miR-132 and hsa-miR-339-5p could be found in the brain of both PD and Alzheimer's disease patients [38].…”
Section: Discussionmentioning
confidence: 64%
“…Cells 2021, 10, 1410 2 of 16 For instance, it was demonstrated that hsa-miR-34b and hsa-miR-34c are downregulated in PD, reducing the levels of DJ-1 and Parkin in the brain, two proteins involved in the ubiquitin-proteasome system in neurons, causing cell death. Furthermore, hsa-miR-4639-5p is upregulated in PD and inhibits DJ-1, also promoting cell death [6]. The dysregulation of these miRNAs shows how these molecules can modulate the pathophysiology of PD.…”
Section: Introductionmentioning
confidence: 99%
“…Only recently has it been discovered that the roles of RNAs are not limited to bridging genes and proteins (Carvalho Barbosa et al, 2020 ). The last decade has witnessed the discovery and annotation of thousands of both housekeeping and regulatory ncRNAs, which are emerging as key regulators of gene expression at the transcriptional or post-transcriptional level (Li et al, 2015 ; Merry et al, 2015 ; Yildirim et al, 2020 ; Rezaei et al, 2021 ). Several subtypes of regulatory ncRNAs, including miRNAs, lncRNAs, and circRNAs, are involved in the pathogenesis of PD (Majidinia et al, 2016 ).…”
Section: How Do the Ncrnas Regulate Parkinson’s Disease?mentioning
confidence: 99%
“…Cumulatively, dopamine-associated oxidative stress, dysfunction of synaptic vesicles and misfolding of α-synuclein produce an extending vicious cycle which perpetually results in death of dopaminergic neurons ( 3 ). PD has been associated with dysregulation of several transcripts among them are long non-coding RNAs (lncRNAs) ( 4 ). LncRNAs have possible role in brain development.…”
Section: Introductionmentioning
confidence: 99%